8 Review of guidance

8.1 The review date for a technology appraisal refers to the month and year in which the Guidance Executive will consider whether the technology should be reviewed.

8.2 A review was proposed in March 2012. For details, see the NICE website. In line with usual practice, NICE will consult with the manufacturer, other consultees and commentators to ensure that the timing of the review of this appraisal takes account of the developing evidence base on this drug.

Andrew Dillon
Chief Executive
October 2007